Clene Nanomedicine - CLNN Net Assets per Single Share
Clene Inc. is implementing a strategy to deploy nanoplatforms to combat neurodegeneration, leveraging a high-tech facility in Utah with an autonomous power supply. Revenue is projected from insurance reimbursements for ALS and multiple sclerosis therapies. The book value per common share clearly defines the boundaries of the business's intrinsic value, with -1.94 serving as the current value of this metric.
Clene Inc - analytical breakdowns and key metrics (CLNN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:clene.com, CLNN
Book value per share reflects the portion of equity attributable to a single security by dividing net assets by the total number of shares. By analyzing the trend of book value per share, an investor assesses the resource preservation of Clene Inc., which is critical for sustaining costly nanocatalytic developments in the therapy of ALS and multiple sclerosis.
Competitors of Clene Inc. (CLNN)
Biogen Corp (BIIB) - Net Assets per Single Share|NBIX: Equity per Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|Book Value per Share PRAX|Accounting Value per Share AVXL|Net Assets per Single Share CeriBell (CBLL)|Net Assets per Single Share Prothena Corporation (PRTA)|ALEC: Book Value per Share|Annexon Biosciences Inc. - Net Asset Value per Share|Omeros Corp. (OMER) - Net Assets per Single Share|NGNE - Equity per Share|Book Value per Share ACIU|Net Asset Value per Share Voyager Therapeutics Inc|NMRA - Accounting Value per Share|Accounting Value of a Share Scilex Holding Company, Inc.|TVGN (Tevogen Bio Holdings) - Book Value per Share|Net Assets per Share ACOG (alphacognition.com)|CGTX - Net Assets per Single Share|Equity per Share Inhibikase Therapeutics Inc IKT|SAVA: Book Value per Share|Assertio Holdings, Inc. (ASRT) - Accounting Value per Share|coyatherapeutics.com - Accounting Value per Share|Vistagen (VTGN) - Net Assets per Share|Book Value per Share OVID|Accounting Value per Share ABOS|Net Assets per Single Share CervoMed Inc (CRVO)|Net Assets per Single Share ATHE (alteritytherapeutics.com)|PEPG - Net Assets per Single Share|Jupiter Neurosciences, Inc. - Equity per Share|Relmada Therapeutics, Inc. (RLMD) - Net Assets per Single Share|ANVS: Equity per Share|Net Assets per Single Share gracetx.com|Firefly Neuro (AIFF) - Equity per Share|Book Value per Share KLTO (ANEW Medical)|Net Asset Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share RVPH|Book Value per Share MTVA (metaviatx.com)|Net Assets per Single Share NeurAxis, Inc|Helius Medical Technologies, Inc. - Accounting Value of a Share|PASG (Passage Bio Corp) - Net Assets per Single Share|NEUP - Net Asset Value per Share|NERV (Minerva Neurosciences, Inc.) - Book Value per Share|ATHA (Athira Pharma Inc) - Accounting Value per Share|Net Assets per Single Share Addex Therapeutics, Ltd.|Net Assets per Single Share Alzamend|Cyclerion Therapeutics - Book Value per Share|Net Asset Value per Share PTIX (protagenic.com)|KTTA - Net Assets per Single Share|Equity per Share Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Net Asset Value per Share|Accounting Value per Share Cara Therapeutics, Inc. CARA|chromocell.com (CHRO) - Accounting Value of a Share|ELYM: Book Value per Share|Net Assets per Share ITCI|Net Assets per Single Share Longboard Pharma LBPH|Equity per Share Marinus Pharma (MRNS)|NKGen Biotech, Inc. - Book Value per Share|NRBO - Accounting Value per Share|Accounting Value per Share SAGE (Sage Therapeutics)|SNPX - Net Assets per Share|TRVN (Trevena, Inc) - Book Value per Share|VIGL (Vigil Neuroscience, Inc.) - Accounting Value per Share|Net Assets per Single Share Anew Medical|Net Assets per Single Share CERE